Market Trends of Global Vaginal Rejuvenation Industry
This section covers the major market trends shaping the Vaginal Rejuvenation Market according to our research experts:
Cosmetic Vaginal Rejuvenation Segment is Estimated to Witness Considerable Growth Over the Forecast Period
Vast expansion in the cosmetic vaginal rejuvenation market is anticipated over the forecast period as more women seek out procedures like vaginoplasty, labia majoraplasty, clitoral hood reduction, labiaplasty, and monsplasty. Labiaplasty, for example, accounted for 1.4% of all surgical procedures performed by plastic surgeons worldwide in 2020, as reported by the International Society for Aesthetic Plastic Surgery's 2020 report. Vaginal rejuvenation using energy-based treatment procedures does not involve surgery. Currently, radiofrequency (RF) treatment and carbon dioxide (CO2) laser treatment are the two most common energy-based treatments for vaginal rejuvenation. The Geneveve by Viveve and the ThermiVa are two examples of radiofrequency treatment devices that use electromagnetic radiations to heat tissue as part of the radiofrequency treatment protocol.
The CO2 laser treatment employs laser light that heats the upper layer of the tissue. This will enable the tissues in the lower layer to synthesize more collagen, thus making the skin firm and tight. Examples of devices that work on CO2 laser technology include MonaLisa Touch, FemTouch, and FemiLift. The increasing technological advancements in providing improved products with better features for outstanding results have been driving segment growth over the forecast period. Thus, with the high incidence of labiaplasty procedures being performed along with the increasing awareness and adoption of minimally invasive surgeries, the cosmetic vaginal rejuvenation segment is expected to grow over the forecast period.
Furthermore, according to a research article titled published in April 2021, a comparative analysis was made between surgical and non-surgical methods for vaginal rejuvenation and the study declared that surgical treatment is necessary for severe- and moderate-degree vaginal laxity and non-surgical treatment is sufficient for light-degree vaginal laxity. Such studies focusing on vaginal rejuvenation are likely to boost market growth over the forecast period.
Therefore, owing to the abovementioned factors considerable segment growth is anticipated over the forecast period.
North America is Estimated to Witness Considerable Growth Over the Forecast Period
North America is expected to hold a significant share of the vaginal rejuvenation market due to the increasing number of vaginal procedures with the high disposable income of consumers. Furthermore, the inclination toward minimally invasive and non-invasive women's health procedures and the increasing interest in aesthetic procedures among women in the United States drive the market. For instance, according to the American Society of Plastic Surgeons, 2021 report, a total of 9,725 labiaplasty procedures were performed in the United States in 2020, accounting for 4.19% of the total cosmetic surgical procedures in the nation. Therefore, such instances indicate that the market is expected to witness considerable growth in the North American region.
Key product launches, high concentration of market players or manufacturer's presence, and acquisition & partnerships among major players, and the presence of technologically advanced products in the United States are some of the factors driving the growth of the vaginal rejuvenation market in the country. For instance, the research article published in December 2021, indicated the high efficacy and safety of the device, ThermiVa, which is used in the treatment of vulvovaginal laxity and sexual dysfunction. ThermiVa is a device manufactured by ThermiAesthetics in the United States, for the treatment of vulvovaginal laxity and sexual dysfunction. The article indicated that the device was associated with an improvement in vaginal laxity and sexual dysfunction. Similarly, in December 2020, Viveve Medical Inc. received 510(k) clearance from the U.S. FDA to expand the manufacturing capacity for its consumable treatment tips, which can be employed with Viveve's Cryogen-cooled Monopolar Radiofrequency (CMRF) technology. Thus, owing to such positive developments considerable market growth is anticipated in the country.
Therefore, due to the aforementioned factors, the vaginal rejuvenation market is expected to witness significant growth over the forecast period.
